Leading the way to safer medication
 Crosscheck  Recommender

Atomoxetine

Also known as: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine

Description

Atomoxetine is a highly selective and potent inhibitor of the pre-synaptic noradrenaline transporter, its presumed mechanism of action, without directly affecting the serotonin or dopamine transporters.

ATC Classification

Code
Title
Category
N06BA09
Atomoxetine
N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics

Trade names

Trade name
Countries
ATAMAX

Spain

ATOFAB

Austria

ATOMAID

United Kingdom

ATOMERRA

Australia

AUDALIS

Austria Netherlands

DEZAPREX

Spain

STRATTERA

Australia Austria Canada Cyprus Netherlands

Product Monographs

Monograph
Type
Country
STRATTERA Hard capsules
MPI, EU: SmPC
UK

2D Molecule Structure

Unique Ingredient Identifier (UNII)

ASW034S0B8 - ATOMOXETINE

CAS Registry Number

83015-26-3 - atomoxetine

SNOMED-CT

407037005 - Atomoxetine (substance)

 
Next: Usage >